{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:26:39Z","timestamp":1775838399528,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1010054","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000}}],"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"horizon 2020","doi-asserted-by":"publisher","award":["101003480"],"award-info":[{"award-number":["101003480"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001656","name":"Helmholtz-Gemeinschaft","doi-asserted-by":"publisher","award":["Initiative and Networking Fund"],"award-info":[{"award-number":["Initiative and Networking Fund"]}],"id":[{"id":"10.13039\/501100001656","id-type":"DOI","asserted-by":"publisher"}]},{"name":"covidec","award":["01KI20102"],"award-info":[{"award-number":["01KI20102"]}]},{"DOI":"10.13039\/501100001656","name":"Helmholtz-Gemeinschaft","doi-asserted-by":"publisher","award":["HIDA Trainee Network"],"award-info":[{"award-number":["HIDA Trainee Network"]}],"id":[{"id":"10.13039\/501100001656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>We analyze the relaxation of non-pharmaceutical interventions (NPIs) under an increasing number of vaccinations in Germany. For the spread of SARS-CoV-2 we employ a SIR-type model that accounts for age-dependence and includes realistic contact patterns between age groups. The implementation of NPIs occurs on changed contact patterns, improved isolation, or reduced infectiousness when, e.g., wearing masks. We account for spatial heterogeneity and commuting activities in between regions in Germany, and the testing of commuters is considered as a further NPI. We include the ongoing vaccination process and analyze the effect of the B.1.617.2 (Delta) variant, which is considered to be 40%\u201360% more infectious then the currently dominant B.1.1.7 (Alpha) variant. We explore different opening scenarios under the ongoing vaccination process by assuming that local restrictions are either lifted in early July or August with or without continued wearing of masks and testing. Our results indicate that we can counteract the resurgence of SARS-CoV-2 despite the Delta variant with appropriate timing for the relaxation of NPIs. In all cases, however, school children are hit the hardest.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1010054","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T13:31:26Z","timestamp":1652707886000},"page":"e1010054","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3912-6615","authenticated-orcid":true,"given":"Wadim","family":"Koslow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0906-6984","authenticated-orcid":true,"given":"Martin J.","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1169-1786","authenticated-orcid":true,"given":"Sebastian","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-4180","authenticated-orcid":true,"given":"Margrit","family":"Klitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7021-1573","authenticated-orcid":true,"given":"Daniel","family":"Abele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-3231","authenticated-orcid":true,"given":"Achim","family":"Basermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Meyer-Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"issue":"4","key":"pcbi.1010054.ref001","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2020.06.011","article-title":"Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention","volume":"59","author":"SM Bartsch","year":"2020","journal-title":"American Journal of Preventive Medicine"},{"issue":"6","key":"pcbi.1010054.ref002","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1473-3099(21)00143-2","article-title":"Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study","volume":"21","author":"S Moore","year":"2021","journal-title":"The Lancet Infectious Diseases"},{"key":"pcbi.1010054.ref003","unstructured":"Betsch C, Korn L, Felgendreff L, Eitze S, Schmid P, Sprengholz P, et al. Zusammenfassung und Empfehlungen Welle 40 \u2014 COSMO. COSMO Konsortium; 2020. Available from: https:\/\/projekte.uni-erfurt.de\/cosmo2020\/web\/summary\/40\/."},{"issue":"9","key":"pcbi.1010054.ref004","doi-asserted-by":"crossref","first-page":"e1009288","DOI":"10.1371\/journal.pcbi.1009288","article-title":"Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves","volume":"17","author":"S Bauer","year":"2021","journal-title":"PLoS computational biology"},{"issue":"6","key":"pcbi.1010054.ref005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1473-3099(21)00167-5","article-title":"Risking further COVID-19 waves despite vaccination","volume":"21","author":"S Contreras","year":"2021","journal-title":"The Lancet Infectious Diseases"},{"key":"pcbi.1010054.ref006","doi-asserted-by":"crossref","first-page":"108648","DOI":"10.1016\/j.mbs.2021.108648","article-title":"Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution","author":"MJ K\u00fchn","year":"2021","journal-title":"Mathematical Biosciences"},{"key":"pcbi.1010054.ref007","article-title":"Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA","author":"R Earnest","year":"2021","journal-title":"medRxiv"},{"issue":"24","key":"pcbi.1010054.ref008","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100509","article-title":"Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021","volume":"26","author":"F Campbell","year":"2021","journal-title":"Eurosurveillance"},{"key":"pcbi.1010054.ref009","unstructured":"Scientific Pandemic Influenza Group on Modelling, Operational sub-group (SPI-M-O) for the Scientific Advisory Group for Emergencies (SAGE). Consensus Statementon COVID-19; 2021."},{"issue":"6","key":"pcbi.1010054.ref010","doi-asserted-by":"crossref","first-page":"e2110782","DOI":"10.1001\/jamanetworkopen.2021.10782","article-title":"Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality","volume":"4","author":"MD Patel","year":"2021","journal-title":"JAMA Network Open"},{"issue":"5","key":"pcbi.1010054.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1008849","article-title":"Modelling optimal vaccination strategy for SARS-CoV-2 in the UK","volume":"17","author":"S Moore","year":"2021","journal-title":"PLOS Computational Biology"},{"issue":"1","key":"pcbi.1010054.ref012","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1038\/s41467-021-23938-8","article-title":"Controlling the pandemic during the SARS-CoV-2 vaccination rollout","volume":"12","author":"J Viana","year":"2021","journal-title":"Nature communications"},{"key":"pcbi.1010054.ref013","unstructured":"Maier BF, Burdinski A, Rose AH, Schlosser F, Hinrichs D, Betsch C, et al. Potential benefits of delaying the second mRNA COVID-19 vaccine dose; 2021."},{"key":"pcbi.1010054.ref014","article-title":"COVID-19-Zielimpfquote","volume":"27","author":"RE Weber","year":"2021","journal-title":"Robert Koch Institut: Epidemiologisches Bulletin"},{"issue":"333","key":"pcbi.1010054.ref015","article-title":"Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants in Germany","volume":"22","author":"MJ K\u00fchn","year":"2022","journal-title":"BMC Infectious Diseases"},{"issue":"20","key":"pcbi.1010054.ref016","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMc2104281","article-title":"BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting","volume":"384","author":"N Dagan","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"pcbi.1010054.ref017","article-title":"Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK\u2019s COVID-19 Infection Survey","author":"E Pritchard","year":"2021","journal-title":"medRxiv"},{"issue":"1","key":"pcbi.1010054.ref018","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination","volume":"384","author":"AT Widge","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"pcbi.1010054.ref019","article-title":"Seasonal variation in SARS-CoV-2 transmission in temperate climates","author":"T Gaven\u010diak","year":"2021","journal-title":"medRxiv"},{"issue":"9","key":"pcbi.1010054.ref020","doi-asserted-by":"crossref","first-page":"e1005697","DOI":"10.1371\/journal.pcbi.1005697","article-title":"Projecting social contact matrices in 152 countries using contact surveys and demographic data","volume":"13","author":"K Prem","year":"2017","journal-title":"PLoS computational biology"},{"issue":"9","key":"pcbi.1010054.ref021","doi-asserted-by":"crossref","first-page":"e1002673","DOI":"10.1371\/journal.pcbi.1002673","article-title":"Inferring the Structure of Social Contacts from Demographic Data in the Analysis of Infectious Diseases Spread","volume":"8","author":"L Fumanelli","year":"2012","journal-title":"PLoS Computational Biology"},{"issue":"3","key":"pcbi.1010054.ref022","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M20-6817","article-title":"Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers","volume":"174","author":"H Bundgaard","year":"2021","journal-title":"Annals of Internal Medicine"},{"issue":"51","key":"pcbi.1010054.ref023","doi-asserted-by":"crossref","first-page":"32293","DOI":"10.1073\/pnas.2015954117","article-title":"Face masks considerably reduce COVID-19 cases in Germany","volume":"117","author":"T Mitze","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pcbi.1010054.ref024","article-title":"Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis","volume":"375","author":"S Talic","year":"2021","journal-title":"BMJ"},{"issue":"2251","key":"pcbi.1010054.ref025","doi-asserted-by":"crossref","first-page":"20210151","DOI":"10.1098\/rspa.2021.0151","article-title":"Quantifying the preventive effect of wearing face masks","volume":"477","author":"T Britton","year":"2021","journal-title":"Proceedings of the Royal Society A Mathematical, Physical and Engineering Sciences"},{"issue":"7","key":"pcbi.1010054.ref026","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant","volume":"385","author":"J Lopez Bernal","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"10293","key":"pcbi.1010054.ref027","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(21)01358-1","article-title":"SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness","volume":"397","author":"A Sheikh","year":"2021","journal-title":"The Lancet"},{"key":"pcbi.1010054.ref028","unstructured":"Stowe J, Andrews N, Gower C, Gallagher E, Utsi L, Simmons R, et al. Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) variant; 2021."},{"issue":"41","key":"pcbi.1010054.ref029","doi-asserted-by":"crossref","first-page":"2100920","DOI":"10.2807\/1560-7917.ES.2021.26.41.2100920","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B. 1.617. 2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021","volume":"26","author":"T Harder","year":"2021","journal-title":"Eurosurveillance"},{"key":"pcbi.1010054.ref030","article-title":"No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant","author":"CB Acharya","year":"2021","journal-title":"medRxiv"},{"key":"pcbi.1010054.ref031","article-title":"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B. 1.617. 2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study","author":"A Singanayagam","year":"2021","journal-title":"The Lancet Infectious Diseases"},{"issue":"5","key":"pcbi.1010054.ref032","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41591-021-01316-7","article-title":"Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine","volume":"27","author":"M Levine-Tiefenbrun","year":"2021","journal-title":"Nature medicine"},{"key":"pcbi.1010054.ref033","article-title":"Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution","author":"R Ke","year":"2021","journal-title":"medRxiv"},{"key":"pcbi.1010054.ref034","article-title":"Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study","author":"PY Chia","year":"2021","journal-title":"medRxiv"},{"key":"pcbi.1010054.ref035","first-page":"1","article-title":"Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2","author":"M Levine-Tiefenbrun","year":"2021","journal-title":"Nature Medicine"},{"key":"pcbi.1010054.ref036","unstructured":"Robert Koch-Institute. Coronavirus disease 2019\u2014Daily Situation Report of the Robert Koch-Institute. Robert Koch-Institute; 2021. Available from: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Jun_2021\/2021-06-06-de.pdf?__blob=publicationFile."},{"key":"pcbi.1010054.ref037","unstructured":"BMAS. Pendlerverflechtungen der sozialversicherungspflichtig Besch\u00e4ftigten nach Kreisen\u2014Deutschland (Jahreszahlen); 2020. Available from: https:\/\/statistik.arbeitsagentur.de\/SiteGlobals\/Forms\/Suche\/Einzelheftsuche_Formular.html?topic_f=beschaeftigung-sozbe-krpendd."},{"key":"pcbi.1010054.ref038","unstructured":"Fehlberg E. Low-order classical Runge-Kutta formulas with stepsize control and their application to some heat transfer problems. vol. 315. National aeronautics and space administration; 1969."},{"key":"pcbi.1010054.ref039","unstructured":"Robert Koch-Institute. Coronavirus disease 2019\u2014Weekly Situation Report of the Robert Koch-Institute. Robert Koch-Institute; 2021. Available from: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Wochenbericht\/Wochenbericht_2021-11-04.pdf?__blob=publicationFile."},{"key":"pcbi.1010054.ref040","unstructured":"Robert Koch-Institute. COVID-19-Impfungen in Deutschland. Berlin: Zenodo. 2021."},{"key":"pcbi.1010054.ref041","unstructured":"Robert Koch-Institute. Coronavirus disease 2019\u2014Weekly Situation Report of the Robert Koch-Institute. Robert Koch-Institute; 2021. Available from: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Wochenbericht\/Wochenbericht_2021-08-19.pdf?__blob=publicationFile."},{"issue":"3","key":"pcbi.1010054.ref042","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/00343404.2014.923093","article-title":"Three-step method for delineating functional labour market regions","volume":"50","author":"P Kropp","year":"2016","journal-title":"Regional Studies"},{"key":"pcbi.1010054.ref043","unstructured":"Zika G, Schneemann C, Hummel M, Maier T, Kalinowski M, Bernardt F, et al. Langfristige Folgen von Demografie und Strukturwandel f\u00fcr regionale Arbeitsm\u00e4rkte. IAB-Forschungsbericht; 2020."},{"key":"pcbi.1010054.ref044","unstructured":"Regionaldatenbank Deutschland. Fortschreibung des Bev\u00f6lkerungsstandes: 12411-02-03-4 Bev\u00f6lkerung nach Geschlecht und Altersgruppen (17)\u2014Stichtag 31.12.\u2014regionale Tiefe: Kreise und krfr. St\u00e4dte; 2022. Available from: https:\/\/www.regionalstatistik.de\/genesis\/online?operation=statistic&levelindex=0&levelid=1646144362683&code=12411#abreadcrumb."},{"key":"pcbi.1010054.ref045","unstructured":"Robert Koch-Institute. Impfdashboard. Robert Koch-Institute; 2021. Available from: https:\/\/impfdashboard.de\/."},{"key":"pcbi.1010054.ref046","unstructured":"Robert Koch-Institute. RKI infection prevention; 2021. Available from: https:\/\/www.rki.de\/DE\/Content\/Infekt\/Impfen\/ImpfungenAZ\/COVID-19\/Infoblatt_Impfung_Kinder_und_Jugendliche.html."},{"key":"pcbi.1010054.ref047","unstructured":"Robert Koch-Institute. Coronavirus disease 2019\u2014Daily Situation Report of the Robert Koch Institute. Robert Koch-Institute; 2021. Available from: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/."},{"key":"pcbi.1010054.ref048","article-title":"Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data","author":"E Volz","year":"2021","journal-title":"medRxiv"},{"key":"pcbi.1010054.ref049","unstructured":"Robert Koch-Institute. RKI Variants Report; 2021. Available from: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/DESH\/Berichte-VOC-tab.html;jsessionid=356B2803E5034ECEA1CD752F635B46A0.internet051?nn=13490888."},{"key":"pcbi.1010054.ref050","unstructured":"Public Health England. SARS-CoV-2 variants of concern and variants under investigation in England; 2021. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/991343\/Variants_of_Concern_VOC_Technical_Briefing_14.pdf."},{"key":"pcbi.1010054.ref051","unstructured":"Robert Koch-Institute. RKI Covid-19 Germany; 2021. Available from: https:\/\/experience.arcgis.com\/experience\/478220a4c454480e823b17327b2bf1d4."},{"key":"pcbi.1010054.ref052","unstructured":"Deutsche Interdisziplin\u00e4re Vereinigung f\u00fcr Intensiv- und Notfallmedizin (DIVI). DIVI Intensivregister; 2021. Available from: https:\/\/www.intensivregister.de\/#\/aktuelle-lage\/downloads."},{"key":"pcbi.1010054.ref053","unstructured":"Abele D, K\u00fchn MJ, Koslow W, Siggel M, Klitz M, Rack K, et al. MEmilio\u2014a high performance Modular EpideMIcs simuLatIOn software; 2021. Available from: https:\/\/github.com\/DLR-SC\/memilio."},{"key":"pcbi.1010054.ref054","unstructured":"Robert Koch-Institute. Coronavirus disease 2019\u2014Daily Situation Report of the Robert Koch-Institute. Robert Koch-Institute; 2021. Available from: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Sept_2021\/2021-09-03-de.pdf?__blob=publicationFile."},{"key":"pcbi.1010054.ref055","unstructured":"Bonin H, Eichhorst W, Kaczynska J, K\u00fcmmerling A, Rinne U, Scholten A, et al. Verbreitung und Auswirkungen von mobiler Arbeit und Homeoffice; 2020-10-13. Available from: https:\/\/www.bmas.de\/DE\/Service\/Publikationen\/Forschungsberichte\/fb-549-verbreitung-auswirkungen-mobiles-arbeiten.html."},{"key":"pcbi.1010054.ref056","doi-asserted-by":"crossref","first-page":"100122","DOI":"10.1016\/j.lanepe.2021.100122","article-title":"Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study","volume":"6","author":"M Augustin","year":"2021","journal-title":"The Lancet Regional Health\u2014Europe"},{"key":"pcbi.1010054.ref057","article-title":"Age-dependent effects in the transmission and control of COVID-19 epidemics","author":"NG Davies","year":"2020","journal-title":"medRxiv"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1010054","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T13:59:26Z","timestamp":1653573566000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010054"}},"subtitle":[],"editor":[{"given":"Claudio Jos\u00e9","family":"Struchiner","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1010054","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.09.21260257","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]}}}